Home › Interstitial Lung Diseases › New Mexico › Albuquerque
Interstitial Lung Diseases clinical trials in Albuquerque, NM
4 studies for Interstitial Lung Diseases are looking for participants at sites in and around Albuquerque (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Recruiting
- University of New Mexico, Albuquerque
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RecruitingPhase 2
- Clinical Research Site, Albuquerque
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- University of New Mexico Health Sciences Center, Albuquerque
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecruitingPhase 3
- University of New Mexico, Albuquerque
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY17 studies
- Philadelphia, PA16 studies
- Los Angeles, CA14 studies
- Kansas City, KS13 studies
- Durham, NC13 studies
- Houston, TX12 studies
- Chicago, IL12 studies
- Charleston, SC11 studies
- Ann Arbor, MI11 studies
- Aurora, CO10 studies
- Boston, MA9 studies
- Rochester, MN9 studies
Other studies in Albuquerque
- Breast Cancer17 studies
- Non-Small Cell Lung Cancer17 studies
- Cancer (all types)14 studies
- Lung Cancer14 studies
- Ovarian Cancer13 studies
- Endometrial Cancer12 studies
- Cardiovascular Disease11 studies
- Metastatic Cancer11 studies
- Prostate Cancer10 studies
- Type 2 Diabetes10 studies
- Acute Myeloid Leukemia9 studies
- Melanoma9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.